检索结果 - Yoshitaka Inaba

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Clinical Value of CT-Guided Needle Biopsy for Retroperitoneal Lesions

    Clinical Value of CT-Guided Needle Biopsy for Retroperitoneal Lesions 由 Yuki Tomozawa, Yoshitaka Inaba, Hidekazu Yamaura, Yozo Sato, Mina Kato, Takaaki Kanamoto, Makoto Sakane

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology

    Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology 由 Toshihiro Tanaka, Y Arai, Yoshitaka Inaba, Masayoshi Inoue, Hideyuki Nishiofuku, Hiroshi Anai, Satoshi Hori, Hiroshi Sakaguchi, Kimihiko Kichikawa

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial

    Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial 由 Masatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, Yoshitaka Inaba, Yasunari Sakamoto, Masayuki Kurosaki, Yoshiko Umeyama, Yoichi Kamei, Junichiro Yoshimitsu, Yosuke Fujii, Mana Aizawa, Paul B. Robbins, Junji Furuse

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy

    Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy 由 Seiichiro Mitani, Shigenori Kadowaki, Azusa Komori, Keiji Sugiyama, Yukiya Narita, Hiroya Taniguchi, Takashi Ura, Masashi Ando, Yozo Sato, Hidekazu Yamaura, Yoshitaka Inaba, Makoto Ishihara, Tsutomu Tanaka, Masahiro Tajika, Kei Muro

    出版 2017
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment

    Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Impl... 由 Kazuomi Ueshima, Atsushi Komemushi, Takeshi Aramaki, Hideki Iwamoto, Shuntaro Obi, Yozo Sato, Toshihiro Tanaka, Kiyoshi Matsueda, Michihisa Moriguchi, Hiroya Saito, Miyuki Sone, Takuji Yamagami, Yoshitaka Inaba, Masatoshi Kudo, Yasuaki Arai

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

    Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD 由 Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Satoshi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji Furuse

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

    Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial 由 M. Ikeda, Satoshi Shimizu, Tosiya Sato, Manabu Morimoto, Yasushi Kojima, Yoshitaka Inaba, Atsushi Hagihara, Masatoshi Kudo, Shoji Nakamori, Shuichi Kaneko, Rie Sugimoto, T. Tahara, Takumi Ohmura, K. Yasui, Kiyoshi Sato, Hiroshi Ishii, Junji Furuse, Takuji Okusaka

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302

    Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302 由 Masafumi Ikeda, Yasuaki Arai, Yoshitaka Inaba, Toshihiro Tanaka, Shunsuke Sugawara, Yoshihisa Kodama, Takeshi Aramaki, Hiroshi Anai, Shinichi Morita, Yoshinori Tsukahara, Hiroshi Seki, Mikio Sato, Kenya Kamimura, Kimei Azama, Masakatsu Tsurusaki, Eiji Sugihara, Masaya Miyazaki, Tatsushi Kobayashi, Miyuki Sone

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

    REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset 由 Tatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda, Namiki Izumi, Ryosuke Tateishi, Masafumi Ikeda, Hiroshi Aikata, Yasunori Kawaguchi, Yoshiyuki Wada, Kazushi Numata, Yoshitaka Inaba, Ryoko Kuromatsu, Masahiro Kobayashi, Takuji Okusaka, Toshiyuki Tamai, Chifumi Kitamura, Kenichi Saito, Katsuya Haruna, Kiwamu Okita, Hiromitsu Kumada

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination wit... 由 Yoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, Yoshitaka Inaba, Tatsuya Yamashita, Hideki Iwamoto, Makoto Ueno, Sadahisa Ogasawara, Teiji Kuzuya, Takahiro Kodama, Yozo Sato, Toshifumi Tada, Kaoru Tsuchiya, Hideyuki Nishiofuku, Koichiro Yamakado, Miyuki Sone, Masafumi Ikeda, Tetsuo Takehara, Tetsutaro Hamano, Masatoshi Kudo

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-... 由 Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki, Toru Ishikawa, Yoshitaka Inaba, Naoki Morimoto, Hiroshi Aikata, Nobukazu Tanabe, Yoshiyuki Wada, Yasuteru Kondo, Masahiro Tsuda, Kazuhiko Nakao, Takanori Ito, Tetsuya Hosaka, Yusuke Kawamura, Teiji Kuzuya, Shunsuke Nojiri, Chikara Ogawa, Hironori Koga, Keisuke Hino, Masafumi Ikeda, Michihisa Moriguchi, Takashi Hisai, Kenichi Yoshimura, Junji Furuse, Yasuaki Arai

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology

    Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, a... 由 Hiroyuki Shibata, Shunsuke Kato, Ikuo Sekine, Koichi Abe, Nobukazu Araki, Haruo Iguchi, Takashi Izumi, Yoshitaka Inaba, Iwao Osaka, Shunsuke Kato, Akira Kawai, Seigo Kinuya, Makoto Kodaira, Eisuke Kobayashi, Takeshi Kobayashi, Junya Sato, Nobuo Shinohara, Shunji Takahashi, Yasushi Takamatsu, Koichi Takayama, Koichi Takayama, Ukihide Tateishi, Hisayasu Nagakura, Masami Hosaka, Hideo Morioka, Takuya Moriya, Takeshi Yuasa, Takashi Yurikusa, Kinomi Yomiya, Masahiro Yoshida

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  13. 13
    1437 Analysis by treatment period and liver function in EMERALD-1: a phase 3 study of durvalumab ± bevacizumab + TACE in participants with embolization-eligible unresectable hepatocellular carcinoma

    1437 Analysis by treatment period and liver function in EMERALD-1: a phase 3 study of durvalumab ± bevacizumab + TACE in participants with embolization-eligible unresectable hepato... 由 Stephen L. Chan, Masatoshi Kudo, Thomas Decaens, Joseph P. Erinjeri, Shukui Qin, Zhenggang Ren, Yasuaki Arai, Mohamed Bouattour, В. В. Бредер, Shi-Ming Lin, Jeong Heo, Jean‐Marie Péron, Vincenzo Mazzaferro, Quang T. Nguyen, Joong‐Won Park, Lünan Yan, Alejandro Molina Alavez, Chang-Fang Chiu, Kwong‐Ming Kee, Florinda Santos, Aibing Xu, Anil Veluvolu, Yoshitaka Inaba, Satheesh Chiradoni Thungappa, Farshid Dayyani, David Hsieh, Vaidehi Dave, Claire Morgan, Kerry Parsons, Mallory Makowsky, Riccardo Lencioni, Bruno Sangro

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: